• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载冬凌草甲素纳米结构脂质载体的制备及特性研究——一种控制释放给药系统。

Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.

机构信息

Department of Pharmaceutics, College of Pharmacy, Shandong University, Jinan, PR China.

出版信息

J Microencapsul. 2010 May;27(3):234-41. doi: 10.3109/02652040903079526.

DOI:10.3109/02652040903079526
PMID:20113167
Abstract

In order to improve drug entrapment efficiency and loading capacity, nanostructured lipid carriers consisting of solid lipid and liquid lipid as a new type of colloidal drug delivery system were prepared. The dispersions of oridonin-loaded solid lipid nanoparticles and nanostructured lipid carriers were successfully prepared by the emulsion-evaporation and low temperature-solidification technique using monostearin as the solid lipid, caprylic/capric triglycerides as the liquid lipid and oridonin as the model drug. Their physicochemical properties of oridonin-loaded nanostructured lipid carriers and release behaviours were investigated and compared with those of solid lipid nanoparticles. As a result, the mean particle size was approximately 200 nm with narrow polydispersity index lower than 0.4 for all developed formulations. Zeta potential values were in the range -35 mV approximately -50 mV, providing good physical stability of all formulations. The differential scanning calorimetry and X-ray diffraction analysis results demonstrated lipid nanoparticles exhibited crystal order disturbance and thus left more space to accommodate drug molecules. The improved drug entrapment efficiency and loading capacity were observed for nanostructured lipid carriers and they enhanced with increasing the caprylic/capric triglycerides content. In vitro drug release experiments exhibited biphasic drug release patterns with burst release initially and prolonged release afterwards. These results indicated that nanostructured lipid carriers could potentially be exploited as a delivery system with improved drug entrapment efficiency and controlled drug release.

摘要

为了提高药物包封效率和载药量,采用固态脂质和液态脂质作为新型胶体药物传递系统的纳米结构脂质载体被制备。通过乳化蒸发和低温固化技术,以单硬脂酸甘油酯作为固态脂质、辛酸/癸酸三酸甘油酯作为液态脂质和冬凌草甲素作为模型药物,成功制备了冬凌草甲素固体脂质纳米粒和纳米结构脂质载体的分散体。考察并比较了载冬凌草甲素的纳米结构脂质载体的理化性质和释放行为与固体脂质纳米粒的差异。结果表明,所有制剂的平均粒径约为 200nm,多分散指数均低于 0.4。Zeta 电位值在-35mV 至-50mV 范围内,为所有制剂提供了良好的物理稳定性。差示扫描量热法和 X 射线衍射分析结果表明,脂质纳米粒表现出晶体有序性的紊乱,从而为药物分子提供了更多的容纳空间。纳米结构脂质载体的药物包封效率和载药量得到提高,且随着辛酸/癸酸三酸甘油酯含量的增加而增加。体外药物释放实验显示出双相药物释放模式,初始突释,随后持续释放。这些结果表明,纳米结构脂质载体有望作为一种药物包封效率提高和药物释放控制的新型给药系统。

相似文献

1
Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.载冬凌草甲素纳米结构脂质载体的制备及特性研究——一种控制释放给药系统。
J Microencapsul. 2010 May;27(3):234-41. doi: 10.3109/02652040903079526.
2
In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.载奥定宁长循环纳米结构脂质载体的体内外评价。
Int J Biol Macromol. 2012 Apr 1;50(3):523-9. doi: 10.1016/j.ijbiomac.2012.01.024. Epub 2012 Jan 24.
3
Preparation and characterization of silybin-loaded nanostructured lipid carriers.水飞蓟宾载药纳米脂质载体的制备与表征。
Drug Deliv. 2010 Jan;17(1):11-8. doi: 10.3109/10717540903431586. Epub 2009 Nov 26.
4
Preparation and characteristics of monostearin nanostructured lipid carriers.单硬脂酸甘油酯纳米结构脂质载体的制备及其特性
Int J Pharm. 2006 May 11;314(1):83-9. doi: 10.1016/j.ijpharm.2006.01.040. Epub 2006 Mar 24.
5
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.水体系中溶剂扩散法制备硬脂酸纳米结构脂质载体及其表征
Colloids Surf B Biointerfaces. 2005 Nov 10;45(3-4):167-73. doi: 10.1016/j.colsurfb.2005.08.005. Epub 2005 Sep 27.
6
Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?载克霉唑固体脂质纳米粒(SLNs)和纳米结构脂质载体(NLCs)的制备、表征及比较评价:NLCs 是否优于 SLNs?
Eur J Pharm Sci. 2012 Aug 30;47(1):139-51. doi: 10.1016/j.ejps.2012.05.010. Epub 2012 Jun 1.
7
Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.载药纳米结构脂质载体的制备及表征。
Drug Dev Ind Pharm. 2010 Jul;36(7):773-80. doi: 10.3109/03639040903485716.
8
Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.用于靶向脑部的纳米结构脂质载体的理化特性表征及体内生物发光成像:以阿扑吗啡为模型药物。
Nanotechnology. 2010 Oct 8;21(40):405101. doi: 10.1088/0957-4484/21/40/405101. Epub 2010 Sep 8.
9
In vivo studies on the oridonin-loaded nanostructured lipid carriers.载有冬凌草甲素的纳米结构脂质载体的体内研究。
Drug Deliv. 2012 Aug;19(6):286-91. doi: 10.3109/10717544.2012.704096. Epub 2012 Aug 28.
10
[Preparation and in vitro characterization of apigemin-loaded nanostructured lipid carriers].载阿匹吉明纳米结构脂质载体的制备及其体外特性研究
Zhong Yao Cai. 2011 Jun;34(6):962-5.

引用本文的文献

1
Design of Clofazimine-Loaded Lipid Nanoparticles Using Smart Pharmaceutical Technology Approaches.运用智能制药技术方法设计载氯法齐明脂质纳米粒
Pharmaceutics. 2025 Jul 2;17(7):873. doi: 10.3390/pharmaceutics17070873.
2
Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation.用于透皮给药的载缬沙坦纳米脂质体快速溶解微针的研制:体外和离体评价
Pharmaceutics. 2025 Apr 7;17(4):483. doi: 10.3390/pharmaceutics17040483.
3
Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis.
冬凌草甲素通过靶向 TNF-α/雄激素受体/TGF-β信号通路轴抑制胃癌 SGC-7901 细胞增殖。
J Cell Mol Med. 2023 Sep;27(18):2661-2674. doi: 10.1111/jcmm.17841. Epub 2023 Jul 11.
4
Formulation Development and Investigations on Therapeutic Potential of Nanogel from L. Extract in Testosterone-Induced Alopecia.从 L. 提取物的纳米凝胶的配方开发和治疗潜力研究雄激素性脱发。
Biomed Res Int. 2023 Jan 31;2023:1777631. doi: 10.1155/2023/1777631. eCollection 2023.
5
Curcumin Nanoparticles Enhance Antioxidant Efficacy of Diclofenac Sodium in Experimental Acute Inflammation.姜黄素纳米颗粒增强双氯芬酸钠在实验性急性炎症中的抗氧化功效。
Biomedicines. 2021 Dec 28;10(1):61. doi: 10.3390/biomedicines10010061.
6
Transdermal Drug Delivery Systems and Their Use in Obesity Treatment.经皮给药系统及其在肥胖症治疗中的应用。
Int J Mol Sci. 2021 Nov 25;22(23):12754. doi: 10.3390/ijms222312754.
7
Phytol-Loaded Solid Lipid Nanoparticles as a Novel Anticandidal Nanobiotechnological Approach.负载叶绿醇的固体脂质纳米粒作为一种新型抗念珠菌纳米生物技术方法
Pharmaceutics. 2020 Sep 13;12(9):871. doi: 10.3390/pharmaceutics12090871.
8
Solubility and Bioavailability Enhancement of Oridonin: A Review.冬凌草甲素增溶和生物利用度提高的研究进展:综述
Molecules. 2020 Jan 14;25(2):332. doi: 10.3390/molecules25020332.
9
Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.原前体凝胶衍生的尼莫司汀:一种持续改善酒石酸溴莫尼定眼部递药的方法;制剂、体外特征及体内药效学研究。
Drug Deliv. 2019 Dec;26(1):509-521. doi: 10.1080/10717544.2019.1609622.
10
The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature Review.变量对固体脂质纳米粒和纳米结构脂质载体粒径的影响;比较文献综述
Adv Pharm Bull. 2016 Jun;6(2):143-51. doi: 10.15171/apb.2016.021. Epub 2016 Jun 30.